Paul Tudor Jones's EWTX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 29,889 shares of Edgewise Therapeutics, Inc. (EWTX) worth $941,504, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in EWTX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 29,889 shares. Largest reduction occurred in Q3 2025, reducing 41,663 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Edgewise Therapeutics (EWTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edgewise Therapeutics (EWTX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +29,889 | New Buy | 29,889 | $31.50 |
| Q3 2025 | -41,663 | Sold Out | 0 | $0.00 |
| Q2 2025 | -5,141 | Reduce 10.98% | 41,663 | $13.11 |
| Q1 2025 | +2,995 | Add 6.84% | 46,804 | $22.00 |
| Q4 2024 | +8,196 | Add 23.01% | 43,809 | $26.70 |
| Q3 2024 | +9,203 | Add 34.85% | 35,613 | $26.69 |
| Q2 2024 | +26,410 | New Buy | 26,410 | $18.01 |
Paul Tudor Jones's Edgewise Therapeutics Investment FAQs
Paul Tudor Jones first purchased Edgewise Therapeutics, Inc. (EWTX) in Q2 2024, acquiring 26,410 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Edgewise Therapeutics, Inc. (EWTX) for 7 quarters since Q2 2024.
Paul Tudor Jones's largest addition to Edgewise Therapeutics, Inc. (EWTX) was in Q1 2026, adding 29,889 shares worth $941,504.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 29,889 shares of Edgewise Therapeutics, Inc. (EWTX), valued at approximately $941,504.
As of the Q1 2026 filing, Edgewise Therapeutics, Inc. (EWTX) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Edgewise Therapeutics, Inc. (EWTX) was 46,804 shares, as reported at the end of Q1 2025.